These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 16116470

  • 1. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.
    Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC.
    Nat Immunol; 2005 Sep; 6(9):928-37. PubMed ID: 16116470
    [Abstract] [Full Text] [Related]

  • 2. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A.
    J Immunol; 2005 Jul 15; 175(2):720-9. PubMed ID: 16002667
    [Abstract] [Full Text] [Related]

  • 3. Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.
    Nausch N, Florin L, Hartenstein B, Angel P, Schorpp-Kistner M, Cerwenka A.
    J Immunol; 2006 Jan 01; 176(1):7-11. PubMed ID: 16365389
    [Abstract] [Full Text] [Related]

  • 4. CD4(+) NKG2D(+) T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1ε transgenic mice.
    Lin Z, Wang C, Xia H, Liu W, Xiao W, Qian L, Jia X, Ding Y, Ji M, Gong W.
    Immunology; 2014 Mar 01; 141(3):401-15. PubMed ID: 24708417
    [Abstract] [Full Text] [Related]

  • 5. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
    Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T.
    Science; 1999 Jul 30; 285(5428):727-9. PubMed ID: 10426993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM, Mahmoud AB, Wight A, Mottashed A, Bélanger S, Rahim MM, Abou-Samra E, Makrigiannis AP.
    Cancer Res; 2014 Jul 15; 74(14):3684-94. PubMed ID: 24802191
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human tumor-derived exosomes down-modulate NKG2D expression.
    Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z.
    J Immunol; 2008 Jun 01; 180(11):7249-58. PubMed ID: 18490724
    [Abstract] [Full Text] [Related]

  • 13. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
    Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier LL.
    Nat Immunol; 2005 Sep 01; 6(9):938-45. PubMed ID: 16086018
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H, Kim J, Cosman D, Choi I.
    Cell Immunol; 2006 Jan 01; 239(1):22-30. PubMed ID: 16630603
    [Abstract] [Full Text] [Related]

  • 17. Regulation of cutaneous malignancy by gammadelta T cells.
    Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC.
    Science; 2001 Oct 19; 294(5542):605-9. PubMed ID: 11567106
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.
    Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, Kaplan DH, Hayday AC, Girardi M.
    Nat Immunol; 2008 Feb 19; 9(2):146-54. PubMed ID: 18176566
    [Abstract] [Full Text] [Related]

  • 20. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM.
    J Immunol; 2003 Dec 15; 171(12):6891-9. PubMed ID: 14662896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.